Related Experiment Video
Updated: Oct 6, 2025

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System
Published on: May 5, 2018
Prevalence of critical congenital heart defects and selected co-occurring congenital anomalies, 2014-2018: A U.S.
Erin Bugenske Stallings1, Jennifer L Isenburg1, Deepa Aggarwal2
1National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Insights
Critical congenital heart defects (CCHDs) affect 1 in 10,000 births, with higher prevalence in American Indian/Alaska Native infants. Over 15% of CCHD cases also have chromosomal defects, highlighting the need for further research.
Area of Science:
- Pediatrics
- Public Health
- Genetics
Background:
- Critical congenital heart defects (CCHDs) are a leading cause of infant morbidity and mortality.
- Early diagnosis and intervention are crucial for improving outcomes in affected newborns.
- This study provides updated prevalence estimates using recent surveillance data.
Purpose of the Study:
- To estimate the prevalence of 12 critical congenital heart defects (CCHDs) using population-based surveillance data.
- To analyze CCHD prevalence by maternal and infant characteristics.
- To determine the co-occurrence of CCHDs with cardiovascular and chromosomal birth defects.
Main Methods:
- Data from 19 U.S. birth defect surveillance programs (2014-2018) were analyzed.
- Prevalence was calculated per 10,000 live births.
- Co-occurrence rates of chromosomal defects were assessed in active case ascertainment programs.
Main Results:
- Overall CCHD prevalence was 19.6 per 10,000 live births.
- American Indian/Alaska Native mothers had the highest CCHD prevalence (28.3 per 10,000).
- 15.8% of CCHD cases had co-occurring chromosomal defects.
Conclusions:
- This study offers updated CCHD prevalence data, stratified by key characteristics.
- Findings highlight ethnic disparities and high rates of co-occurring chromosomal defects.
- Data can inform future research on CCHD risk factors and prevention strategies.
Background:
Critical congenital heart defects (CCHDs) are one of the most common types of birth defects and can lead to significant morbidity and mortality along with surgical or catheter interventions within the first year of life. This report updates previously published estimates of CCHD prevalence with the latest population-based surveillance data from 19 birth defect surveillance programs.
Methods:
The U.S. population-based surveillance programs submitted data on identified cases of 12 CCHDs and co-occurring cardiovascular and chromosomal birth defects from 2014 to 2018. We estimated prevalence by program type and maternal and infant characteristics. Among nine programs with active case ascertainment that collect more than live births, we estimated the percentage of co-occurring cardiovascular and chromosomal birth defects for the 12 CCHDs.
Results:
We identified 18,587 cases of CCHD among all participating programs. Overall CCHD prevalence was 19.6 per 10,000 live births among all 19 programs and 20.2 per 10,000 live births among active programs. Among maternal racial/ethnic groups, infants/fetuses born to American Indian/Alaska Native mothers showed the highest overall prevalence for all CCHDs (28.3 per 10,000) along with eight of the 12 individual CCHDs. Among 7,726 infants/fetuses with CCHD from active case ascertainment programs, 15.8% had at least one co-occurring chromosomal birth defect.
Conclusion:
Our study provides prevalence estimates for CCHDs by maternal and infant characteristics along with co-occurrence with cardiovascular and chromosomal birth defects among infants/fetuses with CCHD using one of the largest and most recent cohorts since the implementation of widespread CCHD screening. These data can provide a basis for future research to better understand risk factors for these defects.
Related Concept Videos
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Teratogenicity
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiovascular System Abnormal Findings II: Auscultation
Abnormal Heart Sounds
Gallops:
Mitral Stenosis I: Introduction
Hazard Ratio
For example, in a clinical trial...

